Literature DB >> 6809187

Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.

C E Mogensen.   

Abstract

Six men aged 26-35 years with proteinuria due to insulindependent juvenile-onset diabetes were treated for moderate hypertension (mean blood pressure 162/103 mm Hg) and studied for a mean of 73 months for the effect on the progression of nephropathy. All patients were of normal weight. During a mean control period of 28 months before treatment the mean glomerular filtration rate (three or four measurements) was 86.1 ml/min and mean 24-hour urinary albumin excretion (also three or four measurements) 3.9 g (range 0.5-8.8 g).During antihypertensive treatment the mean systolic blood pressure fell to 144 mm Hg and mean diastolic pressure to 95 mm Hg. In the control period five patients had shown a mean monthly decline in glomerular filtration rate of 1.23 ml/min; with antihypertensive treatment, however, this decline fell to 0.49 ml/min (2p=0.042). In the remaining patient the glomerular filtration rate was 137 ml/min before treatment and 135 ml/min at the end of the treatment period. In all patients the mean yearly increase in albumin clearance (expressed as a percentage of the glomerular filtration rate) fell from 107% before treatment to 5% during treatment (2p=0.0099).This small study indicates that antihypertensive treatment slows the decline in renal function in diabetic nephropathy. Clinical trials beginning treatment in the incipient phase of diabetic nephropathy will define the optimal modality of treatment in this large patient population.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6809187      PMCID: PMC1499854          DOI: 10.1136/bmj.285.6343.685

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  17 in total

1.  Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1976-07       Impact factor: 1.713

2.  Effect of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate, and renal plasma flow in patients with essential hypertension.

Authors:  E B Pedersen; C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1976-05       Impact factor: 1.713

3.  Increased urinary albumin-excretion rate in benign essential hypertension.

Authors:  H H Parving; C E Mogensen; H A Jensen; P E Evrin
Journal:  Lancet       Date:  1974-06-15       Impact factor: 79.321

4.  Long-term diabetes. A clinical study of 92 patients after 40 years.

Authors:  W G Oakley; D A Pyke; R B Tattersall; P J Watkins
Journal:  Q J Med       Date:  1974-01

5.  Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1971-09       Impact factor: 1.713

6.  Radioimmunoassay for urinary albumin using a single antibody.

Authors:  D W Miles; C E Mogensen; H J Gundersen
Journal:  Scand J Clin Lab Invest       Date:  1970-08       Impact factor: 1.713

Review 7.  Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.

Authors:  D G Gibson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

8.  Arterial pressure in clinically apparent diabetics.

Authors:  H Keen; N S Track; G S Sowry
Journal:  Diabete Metab       Date:  1975-09

9.  The metabolic consequences of adrenergic blockade: a reveiw.

Authors:  J L Day
Journal:  Metabolism       Date:  1975-08       Impact factor: 8.694

10.  Glomerular filtration rate and renal plasma flow in long-term juvenile diabetics without proteinuria.

Authors:  C E Mogensen
Journal:  Br Med J       Date:  1972-11-04
View more
  136 in total

Review 1.  Management of diabetic nephropathy.

Authors:  L Foggensteiner; S Mulroy; J Firth
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

2.  Diabetes mellitus.

Authors:  B Hurwitz; J Yudkin
Journal:  Occas Pap R Coll Gen Pract       Date:  1992-12

3.  Angiotensin converting enzyme inhibitors and diabetic nephropathy.

Authors:  C E Mogensen
Journal:  BMJ       Date:  1992-02-08

Review 4.  Effects of drugs on glucose tolerance in non-insulin-dependent diabetics (Part II).

Authors:  S O'Byrne; J Feely
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

Review 5.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

Review 6.  Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.

Authors:  Emaad M Abdel-Rahman; Lawand Saadulla; W Brian Reeves; Alaa S Awad
Journal:  J Gen Intern Med       Date:  2011-10-18       Impact factor: 5.128

7.  The economics of screening for microalbuminuria in patients with insulin-dependent diabetes mellitus.

Authors:  K Borch-Johnsen
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

Review 8.  Risk predictors in patients with diabetic nephropathy.

Authors:  P Fioretto; M L Caramori; M Dalla Vestra; M Mauer
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 9.  Circadian changes in blood pressure and their relationships to the development of microalbuminuria in type 1 diabetic patients.

Authors:  Donn Hogan; Empar Lurbe; M Reza Salabat; Josep Redon; Daniel Batlle
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 10.  The relationship between glucose control and the development and progression of diabetic nephropathy.

Authors:  Carrie A Phillips; Mark E Molitch
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.